Home Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward
 

Keywords :   


Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

2015-11-14 12:16:55| Biotech - Topix.net

Alnylam has had a summer of discontent as worries about the efficacy and tolerability of a lead drug combine with broader concerns about drug pricing and biotech valuations. Even if revusiran is inferior to Isis's rival compound, a backup compound could more than make up the difference and Alnylam is making broad overall progress with its pipeline.

Tags: multiple forward programs moving

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.11Stocks and dollar rise as US election result in focus
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »